{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T03:24:40Z","timestamp":1789874680112,"version":"4.0.1"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2019,3,10]],"date-time":"2019-03-10T00:00:00Z","timestamp":1552176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Teva Medical Ltd"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,4,19]]},"DOI":"10.1093\/annweh\/wxz010","type":"journal-article","created":{"date-parts":[[2019,1,29]],"date-time":"2019-01-29T07:34:54Z","timestamp":1548747294000},"page":"459-467","source":"Crossref","is-referenced-by-count":18,"title":["Reduction of Contamination with Antibiotics on Surfaces and in Environmental Air in Three European Hospitals Following Implementation of a Closed-System Drug Transfer Device"],"prefix":"10.1093","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8580-0044","authenticated-orcid":false,"given":"Paul J M","family":"Sessink","sequence":"first","affiliation":[{"name":"Exposure Control Sweden AB, Bohus-Bj\u00f6rk\u00f6, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tibor","family":"Nyulasi","sequence":"additional","affiliation":[{"name":"Intensive Care Department, Szent J\u00e1nos Hospital, Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmie L M","family":"Haraldsson","sequence":"additional","affiliation":[{"name":"Department for Infectious Diseases, Central Hospital, V\u00e4xj\u00f6, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Branislava","family":"Rebic","sequence":"additional","affiliation":[{"name":"Pharmacy Department, University Children\u2019s Hospital, Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,3,10]]},"reference":[{"key":"2019041904125603400_CIT0001","first-page":"S51","article-title":"Potential health effects associated with dermal exposure to occupational chemicals","volume":"8","author":"Anderson","year":"2014","journal-title":"Environ Health Insights"},{"key":"2019041904125603400_CIT0002","first-page":"71","article-title":"Hygieniska gr\u00e4nsv\u00e4rden","volume":"2015","author":"Arbetsmilj\u00f6verket","year":"2015","journal-title":"AFS"},{"key":"2019041904125603400_CIT0003","volume-title":"Antibiotic use in the United States: progress and opportunities","author":"CDC","year":"2017"},{"key":"2019041904125603400_CIT0004","first-page":"1455","article-title":"Penicillin sensitivity among hospital nurses without a history of penicillin allergy","volume":"58","author":"Cetinkya","year":"2007","journal-title":"J Adv Nurs"},{"key":"2019041904125603400_CIT0005","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.3747\/co.22.2151","article-title":"Safe handling of cytotoxics: guideline recommendations","volume":"22","author":"Easty","year":"2015","journal-title":"Curr Oncol"},{"key":"2019041904125603400_CIT0006","unstructured":"ECDC\n          . (2017) Surveillance of antimicrobial resistance in Europe 2016. Annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). Available at http:\/\/ecdc.europa.eu\/sites\/portal\/files\/documents\/AMR-surveillance-Europe-2016.pdf. Accessed November 2017."},{"key":"2019041904125603400_CIT0007","article-title":"Directive 89\/391\/EEC. OSH framework directive of 12 June 1989 on the introduction of measures to encourage improvements in the safety and health of workers at work","author":"EU-OSHA","year":"1989"},{"key":"2019041904125603400_CIT0008","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1177\/1078155213482683","article-title":"Determination of the external contamination and cross-contamination by cytotoxic drugs on the surfaces of vials available on the Swiss market","volume":"20","author":"Fleury-Souverain","year":"2014","journal-title":"J Oncol Pharm Pract"},{"key":"2019041904125603400_CIT0009","first-page":"237","article-title":"Occupational dermal exposure to cyclophosphamide in Dutch hospitals: a pilot study","volume":"48","author":"Fransman","year":"2004","journal-title":"Ann Occup Hyg"},{"key":"2019041904125603400_CIT0010","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00420-004-0595-1","article-title":"Dermal exposure to cyclophosphamide in hospitals during preparation, nursing and cleaning activities","volume":"78","author":"Fransman","year":"2005","journal-title":"Int Arch Occup Environ Health"},{"key":"2019041904125603400_CIT0011","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1034\/j.1600-0536.2001.450504.x","article-title":"Occupational allergic contact dermatitis from drugs in healthcare workers","volume":"45","author":"Gielen","year":"2001","journal-title":"Contact Dermat"},{"key":"2019041904125603400_CIT0012","volume-title":"Prevention of work-related airway allergies. Recommended occupational exposure limits and periodic screening","author":"Health Council of the Netherlands","year":"2008"},{"key":"2019041904125603400_CIT0013","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/cod.12616","article-title":"Occupational skin disease among Australian healthcare workers: a retrospective analysis from an occupational dermatology clinic, 1993-2014","volume":"75","author":"Higgins","year":"2016","journal-title":"Contact Dermat"},{"key":"2019041904125603400_CIT0014","first-page":"S3","article-title":"ISOPP standards of practice. Safe handling of cytotoxics. Section 1. Introduction","volume":"13","author":"ISOPP","year":"2007","journal-title":"J Onc Pharm Pract"},{"key":"2019041904125603400_CIT0015","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1177\/10781552070130030107","article-title":"ISOPP standards of practice. Safe handling of cytotoxics. Section 6. Facilities for sterile cytotoxic reconstitution and personal protective equipment","volume":"13","author":"ISOPP","year":"2007","journal-title":"J Onc Pharm Pract"},{"key":"2019041904125603400_CIT0016","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/DER.0000000000000124","article-title":"Occupational dermatitis in health care workers evaluated for suspected allergic contact dermatitis","volume":"26","author":"Kadivar","year":"2015","journal-title":"Dermatitis"},{"key":"2019041904125603400_CIT0017","doi-asserted-by":"crossref","first-page":"85","DOI":"10.4168\/aair.2012.4.2.85","article-title":"IgE sensitization to cephalosporins in health care workers","volume":"4","author":"Kim","year":"2012","journal-title":"Allergy Asthma Immunol Res"},{"key":"2019041904125603400_CIT0018","first-page":"434","article-title":"[A clinical case of occupational allergy to piperacilline. A novel diagnostic method: basophil activation test (BAT)]","volume":"104","author":"Marraccini","year":"2013","journal-title":"Med Lav"},{"key":"2019041904125603400_CIT0019","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1520\/JAI103453","article-title":"Screening of spill and leakage of antibiotics in hospital wards","volume":"8","author":"Nygren","year":"2011","journal-title":"J ASTM Int"},{"key":"2019041904125603400_CIT0020","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/cod.12960","article-title":"Occupational allergic contact dermatitis caused by antibiotics in healthcare workers\u2014relationship with non-immediate drug eruptions","volume":"78","author":"Pinheiro","year":"2018","journal-title":"Contact Dermat"},{"key":"2019041904125603400_CIT0021","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1310\/hpj4904-355","article-title":"Hazardous drug residue on exterior vial surfaces: evaluation of a commercial manufacturing process","volume":"49","author":"Power","year":"2014","journal-title":"Hosp Pharm"},{"key":"2019041904125603400_CIT0022","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1600-0536.1985.tb02539.x","article-title":"Occupational contact urticaria from penicillin","volume":"13","author":"Rudzki","year":"1985","journal-title":"Contact Dermat"},{"key":"2019041904125603400_CIT0023","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1183\/09031936.95.08081421","article-title":"Occupational asthma due to ceftazidime","volume":"8","author":"Stenton","year":"1995","journal-title":"Eur Respir J"},{"key":"2019041904125603400_CIT0024","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1365-2222.1994.tb00208.x","article-title":"Cefotiam-induced IgE-mediated occupational contact anaphylaxis of nurses; case reports, RAST analysis, and a review of the literature","volume":"24","author":"Tadokoro","year":"1994","journal-title":"Clin Exp Allergy"},{"key":"2019041904125603400_CIT0025","unstructured":"Teva Medical Ltd\n          . Available at http:\/\/www.tevadaptor.com"},{"key":"2019041904125603400_CIT0026","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1136\/oem.58.2.138","article-title":"Occupational exposure limits for chemicals","volume":"58","author":"Topping","year":"2001","journal-title":"Occup Environ Med"},{"key":"2019041904125603400_CIT0027","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/ACI.0000000000000248","article-title":"Occupational allergy to pharmaceutical products","volume":"16","author":"Whitaker","year":"2016","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"2019041904125603400_CIT0028","doi-asserted-by":"crossref","first-page":"e0205263","DOI":"10.1371\/journal.pone.0205263","article-title":"Performance testing protocol for closed-system transfer devices used during pharmacy compounding and administration of hazardous drugs","volume":"13","author":"Wilkinson","year":"2018","journal-title":"PLoS One"},{"key":"2019041904125603400_CIT0029","first-page":"S39","article-title":"Extension of the practical shelf life of hazardous drugs using a Closed-System Transfer Device (CSTD) as a container system enabling Drug Vial Optimization (DVO) for up to 28 days","volume":"8","author":"Wilkinson","year":"2014","journal-title":"Eur J Oncol Pharm"}],"container-title":["Annals of Work Exposures and Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/annweh\/article-pdf\/63\/4\/459\/28486494\/wxz010.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,19]],"date-time":"2019-04-19T04:13:41Z","timestamp":1555647221000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/annweh\/article\/63\/4\/459\/5372977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,10]]},"references-count":29,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2019,3,10]]},"published-print":{"date-parts":[[2019,4,19]]}},"URL":"https:\/\/doi.org\/10.1093\/annweh\/wxz010","relation":{},"ISSN":["2398-7308","2398-7316"],"issn-type":[{"value":"2398-7308","type":"print"},{"value":"2398-7316","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,5]]},"published":{"date-parts":[[2019,3,10]]}}}